The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Joy Li
No Relationships to Disclose
 
Nagendra Dhanikonda
No Relationships to Disclose
 
Aangi Shah
No Relationships to Disclose
 
Miraan Jhaveri
No Relationships to Disclose
 
Jasmeet Kaur
No Relationships to Disclose
 
Lucas Viti-Guzman
No Relationships to Disclose
 
Hal Rives
No Relationships to Disclose
 
Fern Anari
No Relationships to Disclose
 
Daniel Geynisman
Honoraria - Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis; Merck; Pfizer; Seattle Genetics/Astellas
Research Funding - Arvinas (Inst); Astellas Pharma (Inst); CG Oncology (Inst); Harpoon therapeutics (Inst); Merck (Inst)
 
Elizabeth Plimack
Consulting or Advisory Role - 23andMe; Abbvie; Adaptimmune; Astellas Pharma; AstraZeneca; Aura Biosciences; Bristol-Myers Squibb/Medarex; Daiichi Sankyo/Lilly; Eisai; EMD Serono; Flatiron Health; Merck; Pfizer; Seagen; Signatera; Urogen pharma
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
 
Matthew Zibelman
Honoraria - Pfizer
Consulting or Advisory Role - Adicet Bio; Exelixis; Merck; Piston Bio
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst)
 
Pooja Ghatalia
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb Foundation (Inst); Merck (Inst)